| Odevelyne Bresca Saint-sauveur, | |
|
818 Haven Oak Ct, Apopka, FL 32703-4464 | |
| (407) 953-9093 | |
| Not Available |
| Full Name | Odevelyne Bresca Saint-sauveur |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 9 Years |
| Location | 818 Haven Oak Ct, Apopka, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720468945 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN 9174002 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Oak Hill Hospital | Brooksville, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sunshine State Anesthesia Partners Llc | 8123434792 | 299 |
News Archive
An ingredient found in abundance in birch bark appears to have an array of metabolic benefits, according to new studies in animals that are reported in the January issue of Cell Metabolism, a Cell Press publication.
The development of nano-biosensors and nanoparticle-based vaccines and medicines has opened a new path toward better management of the coronavirus disease 2019 (COVID-19) pandemic. In a recently published article in the journal ACS Biomaterials Science & Engineering, scientists have reviewed recent advancements in nanotechnology-based diagnostic and therapeutic interventions against human coronaviruses.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.
Kaiser Health News staff writer Phil Galewitz reports: "EHealthInsurance, a large online health insurance broker, had once feared that its business might be imperiled by the health care overhaul.
A child's risk of becoming obese may begin before birth and continue throughout infancy and early childhood - critical periods for cellular growth and development, according to research results discussed during a national conference and outlined in the October supplement to Pediatrics.
› Verified 3 days ago
| Entity Name | Gulf-to-bay Anesthesiology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720039746 PECOS PAC ID: 5092628156 Enrollment ID: O20031106000250 |
News Archive
An ingredient found in abundance in birch bark appears to have an array of metabolic benefits, according to new studies in animals that are reported in the January issue of Cell Metabolism, a Cell Press publication.
The development of nano-biosensors and nanoparticle-based vaccines and medicines has opened a new path toward better management of the coronavirus disease 2019 (COVID-19) pandemic. In a recently published article in the journal ACS Biomaterials Science & Engineering, scientists have reviewed recent advancements in nanotechnology-based diagnostic and therapeutic interventions against human coronaviruses.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.
Kaiser Health News staff writer Phil Galewitz reports: "EHealthInsurance, a large online health insurance broker, had once feared that its business might be imperiled by the health care overhaul.
A child's risk of becoming obese may begin before birth and continue throughout infancy and early childhood - critical periods for cellular growth and development, according to research results discussed during a national conference and outlined in the October supplement to Pediatrics.
› Verified 3 days ago
| Entity Name | Central Brevard Anesthesiologists Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205875671 PECOS PAC ID: 3577477314 Enrollment ID: O20031118000796 |
News Archive
An ingredient found in abundance in birch bark appears to have an array of metabolic benefits, according to new studies in animals that are reported in the January issue of Cell Metabolism, a Cell Press publication.
The development of nano-biosensors and nanoparticle-based vaccines and medicines has opened a new path toward better management of the coronavirus disease 2019 (COVID-19) pandemic. In a recently published article in the journal ACS Biomaterials Science & Engineering, scientists have reviewed recent advancements in nanotechnology-based diagnostic and therapeutic interventions against human coronaviruses.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.
Kaiser Health News staff writer Phil Galewitz reports: "EHealthInsurance, a large online health insurance broker, had once feared that its business might be imperiled by the health care overhaul.
A child's risk of becoming obese may begin before birth and continue throughout infancy and early childhood - critical periods for cellular growth and development, according to research results discussed during a national conference and outlined in the October supplement to Pediatrics.
› Verified 3 days ago
| Entity Name | Us Anesthesia Partners Of Florida Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518910520 PECOS PAC ID: 0345143152 Enrollment ID: O20040129000594 |
News Archive
An ingredient found in abundance in birch bark appears to have an array of metabolic benefits, according to new studies in animals that are reported in the January issue of Cell Metabolism, a Cell Press publication.
The development of nano-biosensors and nanoparticle-based vaccines and medicines has opened a new path toward better management of the coronavirus disease 2019 (COVID-19) pandemic. In a recently published article in the journal ACS Biomaterials Science & Engineering, scientists have reviewed recent advancements in nanotechnology-based diagnostic and therapeutic interventions against human coronaviruses.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.
Kaiser Health News staff writer Phil Galewitz reports: "EHealthInsurance, a large online health insurance broker, had once feared that its business might be imperiled by the health care overhaul.
A child's risk of becoming obese may begin before birth and continue throughout infancy and early childhood - critical periods for cellular growth and development, according to research results discussed during a national conference and outlined in the October supplement to Pediatrics.
› Verified 3 days ago
| Entity Name | Kf Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184031528 PECOS PAC ID: 3779705918 Enrollment ID: O20141104000917 |
News Archive
An ingredient found in abundance in birch bark appears to have an array of metabolic benefits, according to new studies in animals that are reported in the January issue of Cell Metabolism, a Cell Press publication.
The development of nano-biosensors and nanoparticle-based vaccines and medicines has opened a new path toward better management of the coronavirus disease 2019 (COVID-19) pandemic. In a recently published article in the journal ACS Biomaterials Science & Engineering, scientists have reviewed recent advancements in nanotechnology-based diagnostic and therapeutic interventions against human coronaviruses.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.
Kaiser Health News staff writer Phil Galewitz reports: "EHealthInsurance, a large online health insurance broker, had once feared that its business might be imperiled by the health care overhaul.
A child's risk of becoming obese may begin before birth and continue throughout infancy and early childhood - critical periods for cellular growth and development, according to research results discussed during a national conference and outlined in the October supplement to Pediatrics.
› Verified 3 days ago
| Entity Name | Ams National Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316330830 PECOS PAC ID: 3870813025 Enrollment ID: O20150529000613 |
News Archive
An ingredient found in abundance in birch bark appears to have an array of metabolic benefits, according to new studies in animals that are reported in the January issue of Cell Metabolism, a Cell Press publication.
The development of nano-biosensors and nanoparticle-based vaccines and medicines has opened a new path toward better management of the coronavirus disease 2019 (COVID-19) pandemic. In a recently published article in the journal ACS Biomaterials Science & Engineering, scientists have reviewed recent advancements in nanotechnology-based diagnostic and therapeutic interventions against human coronaviruses.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.
Kaiser Health News staff writer Phil Galewitz reports: "EHealthInsurance, a large online health insurance broker, had once feared that its business might be imperiled by the health care overhaul.
A child's risk of becoming obese may begin before birth and continue throughout infancy and early childhood - critical periods for cellular growth and development, according to research results discussed during a national conference and outlined in the October supplement to Pediatrics.
› Verified 3 days ago
| Entity Name | Fpra Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952756728 PECOS PAC ID: 0547554099 Enrollment ID: O20160808000431 |
News Archive
An ingredient found in abundance in birch bark appears to have an array of metabolic benefits, according to new studies in animals that are reported in the January issue of Cell Metabolism, a Cell Press publication.
The development of nano-biosensors and nanoparticle-based vaccines and medicines has opened a new path toward better management of the coronavirus disease 2019 (COVID-19) pandemic. In a recently published article in the journal ACS Biomaterials Science & Engineering, scientists have reviewed recent advancements in nanotechnology-based diagnostic and therapeutic interventions against human coronaviruses.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.
Kaiser Health News staff writer Phil Galewitz reports: "EHealthInsurance, a large online health insurance broker, had once feared that its business might be imperiled by the health care overhaul.
A child's risk of becoming obese may begin before birth and continue throughout infancy and early childhood - critical periods for cellular growth and development, according to research results discussed during a national conference and outlined in the October supplement to Pediatrics.
› Verified 3 days ago
| Entity Name | Sunshine State Anesthesia Partners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437757127 PECOS PAC ID: 8123434792 Enrollment ID: O20210305000003 |
News Archive
An ingredient found in abundance in birch bark appears to have an array of metabolic benefits, according to new studies in animals that are reported in the January issue of Cell Metabolism, a Cell Press publication.
The development of nano-biosensors and nanoparticle-based vaccines and medicines has opened a new path toward better management of the coronavirus disease 2019 (COVID-19) pandemic. In a recently published article in the journal ACS Biomaterials Science & Engineering, scientists have reviewed recent advancements in nanotechnology-based diagnostic and therapeutic interventions against human coronaviruses.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.
Kaiser Health News staff writer Phil Galewitz reports: "EHealthInsurance, a large online health insurance broker, had once feared that its business might be imperiled by the health care overhaul.
A child's risk of becoming obese may begin before birth and continue throughout infancy and early childhood - critical periods for cellular growth and development, according to research results discussed during a national conference and outlined in the October supplement to Pediatrics.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Odevelyne Bresca Saint-sauveur, 818 Haven Oak Ct, Apopka, FL 32703-4464 Ph: (407) 953-9093 | Odevelyne Bresca Saint-sauveur, 818 Haven Oak Ct, Apopka, FL 32703-4464 Ph: (407) 953-9093 |
News Archive
An ingredient found in abundance in birch bark appears to have an array of metabolic benefits, according to new studies in animals that are reported in the January issue of Cell Metabolism, a Cell Press publication.
The development of nano-biosensors and nanoparticle-based vaccines and medicines has opened a new path toward better management of the coronavirus disease 2019 (COVID-19) pandemic. In a recently published article in the journal ACS Biomaterials Science & Engineering, scientists have reviewed recent advancements in nanotechnology-based diagnostic and therapeutic interventions against human coronaviruses.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.
Kaiser Health News staff writer Phil Galewitz reports: "EHealthInsurance, a large online health insurance broker, had once feared that its business might be imperiled by the health care overhaul.
A child's risk of becoming obese may begin before birth and continue throughout infancy and early childhood - critical periods for cellular growth and development, according to research results discussed during a national conference and outlined in the October supplement to Pediatrics.
› Verified 3 days ago
Mr. Anthony Wayne Winston, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3116 Oak Alley Dr, Apopka, FL 32703 Phone: 407-473-8400 | |
Raymond A. Heers, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 522 S Hunt Club Blvd, #572, Apopka, FL 32703 Phone: 407-620-3123 | |
Craig R. Myers, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1367 Longhill Dr, Apopka, Apopka, FL 32712 Phone: 407-880-7358 | |
Paul Winter, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 842 Palm Oak Dr, Apopka, FL 32712 Phone: 407-814-2250 |